Enhancing lysosome function via mTOR/TFEB activation reduces lipofuscin-like granules in early Age-related Macular Degeneration

Ana S Falcão,Mafalda Lopes-da-Silva,Pedro Antas,Cristina Escrevente,Margarida Pedro,Rita Coelho,Inês S Ferreira,Inês P Santos,Thomas Ciossek,Paul Nicklin,Sandra Tenreiro,Miguel C Seabra

DOI: https://doi.org/10.1101/2024.09.17.613413

2024-09-17

Abstract:Age-related macular degeneration (AMD) is the most common blinding disease in the western world and is currently incurable. Although the exact causes of AMD are not clear, the primary origin of pathology appears to be in the retinal pigment epithelium (RPE). RPE is responsible for the daily digestion of photoreceptor outer segments (POS), which imposes a heavy continuous burden on the lysosomal network. POS feeding assay suggested that the accumulation of autofluorescence granules (AFG), similar to lipofuscin derives from lysosomal dysfunction. Here we show that synchronous phagocytosis of POS leads to early transient mTOR activation followed by inhibition in late phagosome maturation. One of its substrates, the transcription factor EB (TFEB) increases during phagosome maturation albeit mostly in its inactive phosphorylated form. We questioned whether induction of the mTOR/TFEB axis could improve digestion of POS and hence reduce AFG load. Treatment of POS-fed cells with rapamycin, an mTORC1 inhibitor after the appearance of AFG results in 30% reduction of AFG load. This effect is dependent on active lysosomal enzymes and induction of active dephosphorylated TFEB with consequent activation of GADD34 and lysosomal biogenesis. As a proof of concept, we show that overexpressing a constitutively active form of unphosphorylated TFEB dramatically reduces POS-dependent AFG accumulation. Overall, this study suggests that viral or pharmacological approaches activating the mTOR/TFEB axis in the RPE could be beneficial as cell-protective treatment of early/intermediate cases of AMD, acting to delay progression of the disease.

Molecular Biology

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore methods to enhance lysosomal function by activating the mTOR/TFEB axis, thereby reducing the accumulation of lipofuscin-like granules in early age-related macular degeneration (AMD).

#### Specific Issues:
1. **Causes of Lipofuscin-like Granule Accumulation**: The paper points out that in retinal pigment epithelial (RPE) cells, lysosomal dysfunction leads to incomplete digestion of photoreceptor outer segments (POS), resulting in the formation of lipofuscin-like granules.
2. **Mechanism of the mTOR/TFEB Axis**: The study found that during POS phagocytosis, mTOR is transiently activated and then inhibited, while TFEB increases during phagocytosis but remains mostly in an inactive phosphorylated state.
3. **Effect of Drug Intervention**: By using rapamycin (an mTORC1 inhibitor), the accumulation of lipofuscin-like granules can be reduced to some extent, and this effect depends on the activity of lysosomal enzymes and the induction of the dephosphorylated form of TFEB.
4. **Potential of Gene Therapy**: Overexpression of non-phosphorylated TFEB can significantly reduce POS-dependent lipofuscin-like granule accumulation, suggesting that activating TFEB could be a potential therapeutic strategy.

### Summary
The main goal of this paper is to improve lysosomal function in RPE cells by activating the mTOR/TFEB axis, thereby reducing the accumulation of lipofuscin-like granules and slowing the progression of early to intermediate AMD. The research results indicate that activating TFEB through drug or gene therapy methods can effectively reduce the accumulation of toxic substances, showing significant clinical application prospects.